APP and Alzheimer disease: Previously, we reported that suppression of AdipoR1 promotes metabolic dysfunction associated with AD-like pathology and memory deficit [82], while intraperitoneal injection of osmotin alleviated neuropathological and neurobehavioral deficits in APP/PS1 mice [33].